These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?]. Dussol B; Berland Y Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717 [TBL] [Abstract][Full Text] [Related]
23. [Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice]. Royo-Bordonada MÁ; Armario P; Lobos Bejarano JM; Pedro-Botet J; Villar Álvarez F; Elosua R; Brotons Cuixart C; Cortés O; Serrano B; Camafort Babkowski M; Gil Núñez A; Pérez A; Maiques A; de Santiago Nocito A; de Castro A; Alegría E; Baeza C; Herranz M; Sans S; Campos P; Semergen; 2017; 43(4):295-311. PubMed ID: 28532894 [TBL] [Abstract][Full Text] [Related]
24. Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Royo-Bordonada MÁ; Armario P; Lobos Bejarano JM; Pedro-Botet J; Villar Alvarez F; Elosua R; Brotons Cuixart C; Cortés O; Serrano B; Camafort Babkowski M; Gil Núñez A; Pérez A; Maiques A; de Santiago Nocito A; Castro A; Alegría E; Baeza C; Herranz M; Sans S; Campos P; Clin Investig Arterioscler; 2017; 29(2):69-85. PubMed ID: 28173956 [TBL] [Abstract][Full Text] [Related]
25. Early specialist care for diabetes: who benefits most? A propensity score-matched cohort study. Booth GL; Shah BR; Austin PC; Hux JE; Luo J; Lok CE Diabet Med; 2016 Jan; 33(1):111-8. PubMed ID: 25981183 [TBL] [Abstract][Full Text] [Related]
26. [Characteristics and cardiovascular events in a general population included in the RICARTO (RIesgo CARdiovascular TOledo) study: Data from the first 1,500 individuals included in the study]. Rodríguez-Roca GC; Segura-Fragoso A; Villarín-Castro A; Alonso-Moreno FJ; Rodríguez-Padial L; Rodríguez-García ML; Fernández-Conde JA; Rojas-Martelo GA; Menchén-Herreros A; Escobar-Cervantes C; Fernández-Martín J; Artigao-Rodenas LM; Carbayo-Herencia JA; Hernández-Moreno J; Semergen; 2018 Apr; 44(3):180-191. PubMed ID: 28869129 [TBL] [Abstract][Full Text] [Related]
27. Consensus document on the management of the atherogenic dyslipidaemia of the Spanish Society of Arteriosclerosis. Ascaso JF; Millán J; Hernández-Mijares A; Blasco M; Brea Á; Díaz Á; Mantilla T; Pedro-Botet J; Pintó X; Clin Investig Arterioscler; 2017; 29(2):86-91. PubMed ID: 28185675 [TBL] [Abstract][Full Text] [Related]
28. The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes. Paty BW Can J Diabetes; 2015 Dec; 39 Suppl 5():S155-9. PubMed ID: 26654859 [TBL] [Abstract][Full Text] [Related]
29. Cardiovascular Safety of Current and Emerging Glucose-Lowering Therapies. Fitchett D Can J Diabetes; 2015 Dec; 39 Suppl 5():S176-82. PubMed ID: 26654861 [No Abstract] [Full Text] [Related]
30. Cardiac rehabilitation in patients with type 2 diabetes mellitus and coronary disease: a comparative study. Toste S; Viamonte S; Barreira A; Fernandes P; Lopes Gomes J; Torres S Rev Port Cardiol; 2014 Oct; 33(10):599-608. PubMed ID: 25307705 [TBL] [Abstract][Full Text] [Related]
31. Effect of lifestyle intervention in patients with type 2 diabetes: a meta-analysis. Chen L; Pei JH; Kuang J; Chen HM; Chen Z; Li ZW; Yang HZ Metabolism; 2015 Feb; 64(2):338-47. PubMed ID: 25467842 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of older persons with diabetes]. Fernández MA Semergen; 2014 May; 40 Suppl 1():10-6. PubMed ID: 25263638 [TBL] [Abstract][Full Text] [Related]
34. [Cardiovascular prevention in diabetes mellitus: A multifactorial challenge]. Pedro-Botet J; Chillarón JJ; Benaiges D; Flores-Le Roux JA Clin Investig Arterioscler; 2016; 28(3):154-63. PubMed ID: 26655375 [TBL] [Abstract][Full Text] [Related]
35. The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM). Basile JN J Diabetes Complications; 2013; 27(3):280-6. PubMed ID: 23375850 [TBL] [Abstract][Full Text] [Related]
36. Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment. Kotsis V; Jordan J; Micic D; Finer N; Leitner DR; Toplak H; Tokgozoglu L; Athyros V; Elisaf M; Filippatos TD; Redon J; Redon P; Antza C; Tsioufis K; Grassi G; Seravalle G; Coca A; Sierra C; Lurbe E; Stabouli S; Jelakovic B; Nilsson PM J Hypertens; 2018 Jul; 36(7):1427-1440. PubMed ID: 29634663 [TBL] [Abstract][Full Text] [Related]